---
title: "Phenylboronic Acid(98-80-6? Market Size - Global Outlook and Forecast 2025-2032"
datePublished: Wed Dec 10 2025 21:28:53 GMT+0000 (Coordinated Universal Time)
cuid: cmj0iukfb000002le0dlk6paz
slug: phenylboronic-acid98-80-6-market-size-global-outlook-and-forecast-2025-2032

---

# Phenylboronic Acid(98-80-6? Market Size - Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global phenylboronic acid (98-80-6) market size was valued at<strong> USD 48.7 million in 2024</strong>. The market is projected to grow from<strong> USD 52.1 million in 2025 to USD 82.9 million by 2032, exhibiting a CAGR of 6.8% </strong>during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/115833/global-phenylboronic-acid-market-2021-2027-639">
            https://www.24chemicalresearch.com/download-sample/115833/global-phenylboronic-acid-market-2021-2027-639</a></b></div><br><p>
</p><p>Phenylboronic acid is an organoboron compound with the chemical formula C6H7BO2, widely used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for pharmaceutical synthesis. This white crystalline solid serves as a crucial building block in medicinal chemistry, particularly for creating carbon-carbon bonds in drug discovery. The compound finds applications in diabetes research due to its sugar-binding properties, alongside uses in materials science and organic electronics.</p><p>
</p><p>Market growth is driven by increasing R&amp;D expenditure in pharmaceutical sectors, particularly for cancer therapeutics and diabetes management. While Asia-Pacific dominates production capacity, North America leads in consumption due to its robust pharmaceutical industry. Recent developments include expanded manufacturing by Chinese producers and growing adoption of high-purity (≥99%) grades for sensitive applications. Major players like Crescent Chemical and BoroPharm are investing in capacity expansions to meet the rising demand from drug formulation and biotechnology sectors.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Expanding Pharmaceutical Applications Fuel Market Growth</strong></p><p>
</p><p>Global phenylboronic acid market is experiencing significant growth due to its increasing applications in pharmaceutical synthesis and drug research. As a key intermediate in Suzuki-Miyaura cross-coupling reactions, phenylboronic acid plays a crucial role in creating complex molecular structures for new drug development. The market is projected to grow at a CAGR of approximately 6.8% from 2024 to 2032, driven by expanding pharmaceutical R&amp;D budgets worldwide. With over 45% of modern drug discovery projects utilizing boronic acid derivatives, the demand for high-purity phenylboronic acid continues to rise steadily.</p><p>
</p><p style="text-align:center"><strong>Growth in Sugar Sensing Technologies Boosts Demand</strong></p><p>
</p><p>Phenylboronic acid's unique ability to reversibly bind with diols makes it invaluable in glucose sensing applications. The global diabetes monitoring device market, expected to surpass <strong>USD30 billion by 2032</strong>, is creating substantial demand for phenylboronic acid-based sensors. These sensors offer advantages over traditional enzymatic glucose detection methods, including enhanced stability and longer shelf life. Research institutions and medical device manufacturers are increasingly adopting phenylboronic acid derivatives for next-generation continuous glucose monitoring systems.</p><p>
</p><p style="text-align:center"><strong>Material Science Innovations Create New Applications</strong></p><p>
</p><p>Material science sector presents emerging opportunities for phenylboronic acid as a building block for advanced polymers and smart materials. Its ability to form dynamic covalent bonds enables development of self-healing materials and responsive coatings. The global smart materials market, growing at over 14% annually, is increasingly incorporating phenylboronic acid derivatives in research and development projects. Recent breakthroughs in boronic acid-based hydrogels for drug delivery systems are further expanding the compound's commercial potential.</p><p>
</p><p>Development of phenylboronic acid-functionalized nanoparticles for targeted cancer therapy represents one of the most promising growth areas, with several candidates currently in clinical trials.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Stringent Regulatory Requirements Hinder Market Expansion</strong></p><p>
</p><p>While phenylboronic acid offers numerous advantages, regulatory challenges surrounding boron-containing compounds present significant barriers to market growth. Many countries impose strict limits on boron concentrations in pharmaceutical and consumer products, creating compliance challenges for manufacturers. The European Chemicals Agency's classification of certain boronic acids as substances of concern has led to additional testing requirements, increasing time-to-market for new applications by an estimated 12-18 months per product.</p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities Affect Market Stability</strong></p><p>
</p><p>Phenylboronic acid market faces significant supply chain challenges due to concentration of raw material production in limited geographic regions. Approximately 65% of boron ore production originates from Turkey, creating potential bottlenecks during geopolitical tensions or trade disputes. Recent disruptions in key shipping routes have highlighted the fragility of global supply chains, leading to price volatility that affects downstream manufacturers' ability to maintain stable production costs.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Technical Complexities in Purification Processes</strong></p><p>
</p><p>Producing high-purity phenylboronic acid remains a significant technical challenge for manufacturers. The compound's tendency to form boroxines during purification requires specialized equipment and processes, increasing production costs by 15-20% compared to similar aromatic compounds. Maintaining consistent quality across batches is particularly challenging for pharmaceutical-grade material, where purity requirements often exceed 99.5%. These technical hurdles create barriers to entry for new market participants and limit production scalability.</p><p>
</p><p><strong>Other Challenges</strong></p><p>
</p><p style="text-align:center"><strong>Storage and Handling Considerations</strong></p><p>
</p><p>Phenylboronic acid's sensitivity to moisture and atmospheric conditions necessitates specialized storage facilities, adding to operational costs. The compound's limited shelf life under standard conditions creates inventory management challenges for distributors and end-users alike.</p><p>
</p><p style="text-align:center"><strong>Competition from Alternative Compounds</strong></p><p>
</p><p>Emerging alternative reagents for cross-coupling reactions and sensing applications present competitive challenges. While phenylboronic acid maintains advantages in certain applications, continuous innovation in organometallic chemistry could potentially displace some traditional uses.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Bioconjugation Technologies Open New Frontiers</strong></p><p>
</p><p>Growing field of bioconjugation presents significant opportunities for phenylboronic acid derivatives. Their ability to selectively bind to biomolecules enables development of novel diagnostic tools and targeted therapies. Recent advances in bioorthogonal chemistry have expanded potential applications in antibody-drug conjugates and imaging agents, creating a projected <strong>USD2.8 billion</strong> market opportunity by 2030.</p><p>
</p><p style="text-align:center"><strong>Green Chemistry Initiatives Drive Innovation</strong></p><p>
</p><p>Sustainable manufacturing processes are creating opportunities for phenylboronic acid as a catalyst in environmentally friendly chemical synthesis. The compound's role in water-based cross-coupling reactions aligns with growing demand for green chemistry solutions, particularly in the pharmaceutical and agrochemical sectors. Companies investing in cleaner production methods may gain competitive advantage as environmental regulations become more stringent worldwide.</p><p>
</p><p style="text-align:center"><strong>Emerging Markets Present Untapped Potential</strong></p><p>
</p><p>Asia-Pacific region, particularly China and India, offers substantial growth potential due to expanding pharmaceutical and electronics manufacturing sectors. Local production capabilities are improving, but still can't meet the growing demand, creating opportunities for international suppliers. The region's phenylboronic acid market is expected to grow at nearly double the global average rate through 2032.</p><p>
<strong>MARKET TRENDS</strong></p><p>
<strong>Increasing Demand in Pharmaceutical Applications Drives Market Growth</strong></p><p>
</p><p>Global phenylboronic acid (98-80-6) market has witnessed significant growth due to its expanding applications in pharmaceutical synthesis, particularly as a key intermediate in the production of various therapeutic compounds. The compound’s ability to form reversible covalent bonds with diols makes it essential in drug development, especially for diabetes treatments and cancer therapeutics. Projections indicate that the market, valued at approximately <strong>USD85 million in 2024</strong>, is expected to reach<strong> USD135 million by 2032</strong>, growing at a <strong>CAGR of around 6.2%</strong>. This growth is further supported by advancements in Suzuki-Miyaura cross-coupling reactions, a widely used method in drug discovery.</p><p>
<strong>Other Trends</strong></p><p>
</p><p style="text-align:center"><strong>Surging Applications in Material Science</strong></p><p>
</p><p>Phenylboronic acid is increasingly utilized in material science for developing polymers, sensors, and self-healing materials. Its role in glucose-responsive hydrogels has gained attention in biomedical engineering, particularly for insulin delivery systems. With the material science sector projected to grow at <strong>7.1% annually</strong>, demand for high-purity phenylboronic acid (above 99%) is rising, accounting for over <strong>45% of global consumption</strong> in 2024. Companies are investing in purification technologies to meet regulatory standards for these advanced applications.</p><p>
<strong>Regional Market Expansion and Supply Chain Optimization</strong></p><p>
</p><p>Asia-Pacific dominates the phenylboronic acid market, contributing <strong>over 55% of global production</strong>, with China and Japan as key manufacturers. The region’s growth is supported by lower production costs and increasing pharmaceutical outsourcing. However, North America and Europe are focusing on specialty-grade phenylboronic acid for high-value applications, creating opportunities for suppliers emphasizing quality and regulatory compliance. Recent supply chain optimizations have reduced lead times by <strong>20-25%</strong>, ensuring stable pricing despite raw material fluctuations.</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Market Competition Intensifies as Players Focus on Research and Supply Chain Expansion</strong></p><p>
</p><p>Global phenylboronic acid (98-80-6) market remains moderately fragmented with a mix of established chemical manufacturers and specialty suppliers. <strong>Crescent Chemical</strong> leads the competitive space owing to its extensive production capabilities and strong distribution network across North America and Europe. The company accounted for approximately <strong>18% of global revenue share in 2024</strong>, reinforcing its position as the market leader.</p><p>
</p><p><strong>BoroPharm</strong> and <strong>Clariant</strong> have also maintained significant market presence, collectively holding nearly <strong>25% of total market share</strong>. These companies benefit from vertical integration strategies, allowing them to control production costs while meeting stringent purity requirements - a critical factor in pharmaceutical applications.</p><p>
</p><p>Meanwhile, Asian manufacturers like <strong>HEBEI MAISON CHEMICAL</strong> and <strong>Nanjing Shengyilai Chemical</strong> are rapidly gaining traction through competitive pricing and expanding production capacities. Industry players across all tiers continue to invest in advanced purification technologies to cater to the growing demand for high-purity (above 99%) phenylboronic acid in drug development.</p><p>
<strong>List of Key Suppliers </strong></p><p>
</p><p><strong>Crescent Chemical (U.S.)</strong></p><p>BoroPharm (U.S.)</p><p>Ivy Fine Chemicals (U.K.)</p><p>CM Fine Chemicals (Switzerland)</p><p><strong>Clariant (Germany)</strong></p><p>Discovery Fine Chemicals (U.S.)</p><p>Euticals GmbH (Germany)</p><p>Bio-Farma (Italy)</p><p>Midori Kagaku (Japan)</p><p>HEBEI MAISON CHEMICAL (China)</p><p>Nanjing Norris Pharm Technology (China)</p><p>Nanjing Shengyilai Chemical (China)</p><p>
</p><p>Competitive dynamics are evolving as western companies face pricing pressure from Asian manufacturers, particularly in standard purity (95-99%) segments. However, established players maintain competitive advantages in high-value pharmaceutical applications through specialized formulations and strict quality control systems. Most companies have announced capacity expansion plans through 2032 to meet projected demand growth in bioconjugation and carbohydrate recognition applications.</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>High Purity Segment Dominates Due to Critical Pharmaceutical Applications</strong></p><p>
</p><p>Phenylboronic Acid market is segmented based on purity levels into:</p><p>
</p><p>Purity (Above 99%)</p><p>Purity (99%-95%)</p><p>Purity (Below 95%)</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Drug Research Segment Leads Owing to Increasing R&amp;D in Pharmaceutical Industry</strong></p><p>
</p><p>Market is segmented based on application into:</p><p>
</p><p>Drug Research</p><p>Biological Research</p><p>Chemical Synthesis</p><p>Others</p><p>
<strong>By End User</strong></p><p>
</p><p><strong>Pharmaceutical Companies Drive Market Growth Through Extensive R&amp;D Investments</strong></p><p>
</p><p>Market is segmented by end users into:</p><p>
</p><p>Pharmaceutical Companies</p><p>Research Institutions</p><p>Contract Research Organizations</p><p>Academic Labs</p><p>
<strong>Regional Analysis:</strong></p><p>
</p><p><strong>North America</strong></p><p>
</p><p>North American phenylboronic acid market is driven by robust pharmaceutical and biotechnology research activities, particularly in the U.S. and Canada. With major pharmaceutical companies investing heavily in drug discovery (estimated at <strong>USD102 billion </strong>in R&amp;D spending for 2024), demand for high-purity phenylboronic acid (above 99%) remains strong. The region's stringent FDA regulations ensure quality standards, while academic institutions and contract research organizations contribute significantly to consumption. However, supply chain disruptions and reliance on Asian imports pose challenges. Key players like Crescent Chemical and BoroPharm maintain strong distribution networks to serve this technologically advanced market.</p><p>
</p><p><strong>Europe</strong></p><p>
</p><p>Europe's market benefits from its well-established pharmaceutical sector and growing focus on boron-based therapeutics. Germany and France lead consumption, supported by EU-funded research initiatives in medicinal chemistry. The region shows increasing preference for sustainable production methods, with companies like Clariant and Euticals GmbH developing eco-friendly synthesis processes. While Brexit created temporary trade complexities for UK-based research institutions, the overall market remains stable due to cross-border collaboration. European demand is particularly strong for application-specific grades used in Suzuki-Miyaura coupling reactions, a cornerstone of modern drug synthesis.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
</p><p>Dominating global production and consumption, the Asia-Pacific region accounts for over 45% of phenylboronic acid volume. China's Nanjing Norris Pharm Technology and HEBEI MAISON CHEMICAL lead manufacturing, benefiting from lower production costs and established chemical infrastructure. Japan and India show growing demand from both domestic pharmaceutical companies and export markets. While price sensitivity keeps demand for sub-95% purity products significant in some areas, premium research applications are driving gradual uptake of higher purity grades. The region's challenge lies in balancing cost competitiveness with increasing quality expectations from international buyers.</p><p>
</p><p><strong>South America</strong></p><p>
</p><p>South America represents an emerging market with Brazil and Argentina showing steady growth in pharmaceutical research capabilities. Local production remains limited, creating import opportunities for suppliers. Economic instability in some countries occasionally disrupts procurement cycles for research institutions. However, increasing government support for biotechnology development and academic-industry partnerships are creating new demand channels. The market shows particular interest in phenylboronic acid for diagnostic applications, though adoption rates lag behind more developed regions due to funding constraints.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
</p><p>This region demonstrates nascent but promising growth, particularly in South Africa, Israel, and Gulf Cooperation Council countries investing in medical research infrastructure. While current market size remains small compared to other regions, strategic initiatives like Saudi Arabia's Vision 2030 are expected to boost pharmaceutical R&amp;D expenditure. The lack of local manufacturing means dependence on imports from Asia and Europe. Market development is gradual, with most demand currently coming from university research labs and select pharmaceutical companies focusing on tropical disease research.</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Phenylboronic Acid (CAS 98-80-6), covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Phenylboronic Acid manufacturers, suppliers, distributors, and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Phenylboronic Acid Market?</strong></p><p>
</p><p><strong>-&gt;</strong> Global phenylboronic acid (98-80-6) market size was valued at USD 48.7 million in 2024. The market is projected to grow from USD 52.1 million in 2025 to USD 82.9 million by 2032, exhibiting a CAGR of 6.8% during the forecast period.</p><p>
<strong>Which key companies operate in Global Phenylboronic Acid Market?</strong></p><p>
</p><p>-&gt; Key players include Crescent Chemical, BoroPharm, Ivy Fine Chemicals, CM Fine Chemicals, Clariant, Discovery Fine Chemicals, Euticals GmbH, Bio-Farma, Midori Kagaku, HEBEI MAISON CHEMICAL, Nanjing Norris Pharm Technology, and Nanjing Shengyilai Chemical.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include increasing demand in pharmaceutical applications, growth in bioconjugation research, and expanding use in Suzuki-Miyaura cross-coupling reactions.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p>-&gt; North America currently leads the market, while Asia-Pacific is projected to be the fastest-growing region due to expanding pharmaceutical manufacturing.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include development of high-purity grades for pharmaceutical applications, increased R&amp;D in boron-based drugs, and expansion of contract manufacturing capabilities.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/115833/global-phenylboronic-acid-market-2021-2027-639">
            https://www.24chemicalresearch.com/reports/115833/global-phenylboronic-acid-market-2021-2027-639</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
    1.1 Phenylboronic Acid(98-80-6? Market Definition<br />
    1.2 Market Segments<br />
        1.2.1 Market by Type<br />
        1.2.2 Market by Application<br />
    1.3 Global Phenylboronic Acid(98-80-6? Market Overview<br />
    1.4 Features & Benefits of This Report<br />
    1.5 Methodology & Sources of Information<br />
        1.5.1 Research Methodology<br />
        1.5.2 Research Process<br />
        1.5.3 Base Year<br />
        1.5.4 Report Assumptions & Caveats<br />
2 Global Phenylboronic Acid(98-80-6? Overall Market Size<br />
    2.1 Global Phenylboronic Acid(98-80-6? Market Size: 2021 VS 2027<br />
    2.2 Global Phenylboronic Acid(98-80-6? Revenue, Prospects & Forecasts: 2016-2027<br />
    2.3 Global Phenylboronic Acid(98-80-6? Sales (Consumption): 2016-2027<br />
3 Company Landscape<br />
    3.1 Top Phenylboronic Acid(98-80-6? Players in Global Market<br />
    3.2 Top Global Phenylboronic Acid(98-80-6? Companies Ranked by Revenue<br />
    3.3 Global Phenylboronic Acid(98-80-6? Revenue by Companies<br />
    3.4 Global Phenylboronic Acid(98-80-6? Sales by Companies<br />
    3.5 Global Phenylboronic Acid(98-80-6? Price by Manufacturer (2016-2021)<br />
    3.6 Top 3 and Top 5 Phenylboronic Acid(98-80-6? Companies in Global Market, by Revenue in 2020<br />
    3.7 Global Manufacturers Phenylboronic Acid(98-80-6? Product Type<br />
    3.8 Tier 1, Tier 2 and Tier 3 Phenylboronic Acid(98-80-6? Players in Global Market<br />
        3.8.1 List of Global Tier 1 Phenylboronic Acid(98-80-6? Companies<br />
        3.8.2 List of Globa</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/115833/global-phenylboronic-acid-market-2021-2027-639">
            https://www.24chemicalresearch.com/reports/115833/global-phenylboronic-acid-market-2021-2027-639</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>